Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

Non-ketotic hyperosmolar hyperglycemic chorea.

Gomes MF, Carvalho Neto EG, Kowacs F, Rieder CRM.

Rev Assoc Med Bras (1992). 2019 Feb;65(2):127-129. doi: 10.1590/1806-9282.65.2.127. No abstract available.

2.

GBA mutations and Parkinson's disease in Brazil.

Rieder CRM.

Arq Neuropsiquiatr. 2019 Feb;77(2):71-72. doi: 10.1590/0004-282X20190013. No abstract available.

3.

Dos and Don’ts avec vos patients douloureux chroniques.

Kaufmann J, Rieder C, Brönnimannc B.

Rev Med Suisse. 2019 Jan 30;15(636):309-310. French. No abstract available.

PMID:
30724524
4.

Dos and Don’ts: Kommunikation in der Schmerzbehandlung. Praxisnahe Checkliste - Wie umgehen mit «schwierigen», schmerz-geplagtenPatientInnen ?

Kaufmann J, Rieder C, Brönnimann B.

Rev Med Suisse. 2019 Jan 30;15(636):266-267. German. No abstract available.

PMID:
30724504
5.

Neuroparacoccidioidomycosis.

Gomes Carvalho Neto E, Coletto A, Biazus PG, Pereira Dos Santos I, Rieder CRM, de Castro Ribeiro M.

Neurol Neuroimmunol Neuroinflamm. 2018 Nov 7;6(1):e519. doi: 10.1212/NXI.0000000000000519. eCollection 2019 Jan. No abstract available.

6.

A 9-Week Nordic and Free Walking Improve Postural Balance in Parkinson's Disease.

Franzoni LT, Monteiro EP, Oliveira HB, da Rosa RG, Costa RR, Rieder C, Martinez FG, Peyré-Tartaruga LA.

Sports Med Int Open. 2018 Jan 8;2(2):E28-E34. doi: 10.1055/s-0043-124757. eCollection 2018 Apr.

7.

Dysphonia and Dysarthria in People With Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation: Effect of Frequency Modulation.

Morello ANDC, Beber BC, Fagundes VC, Cielo CA, Rieder CRM.

J Voice. 2018 Nov 16. pii: S0892-1997(18)30254-6. doi: 10.1016/j.jvoice.2018.10.012. [Epub ahead of print]

PMID:
30454944
8.

Cortisol levels, motor, cognitive and behavioral symptoms in Parkinson's disease: a systematic review.

Soares NM, Pereira GM, Altmann V, de Almeida RMM, Rieder CRM.

J Neural Transm (Vienna). 2019 Mar;126(3):219-232. doi: 10.1007/s00702-018-1947-4. Epub 2018 Oct 29. Review.

PMID:
30374595
9.

Translation, linguistic and cultural adaptation, reliability and validity of the Radboud Oral Motor Inventory for Parkinson's Disease - ROMP questionnaire.

Presotto M, Olchik MR, Kalf JG, Rieder CRM.

Arq Neuropsiquiatr. 2018 May;76(5):316-323. doi: 10.1590/0004-282X20180033.

10.

Clinimetrics of the 9- and 19-Item Wearing-Off Questionnaire: A Systematic Review.

Mantese CE, Schumacher-Schuh A, Rieder CRM.

Parkinsons Dis. 2018 Apr 1;2018:5308491. doi: 10.1155/2018/5308491. eCollection 2018. Review.

11.

The Impact of Deep Brain Stimulation on the Quality of Life and Swallowing in Individuals with Parkinson's Disease.

Olchik MR, Ghisi M, Ayres A, Schuh AFS, Oppitz PP, Rieder CRM.

Int Arch Otorhinolaryngol. 2018 Apr;22(2):125-129. doi: 10.1055/s-0037-1603466. Epub 2017 Jun 5.

12.

Plantar stimulation in parkinsonians: From biomarkers to mobility - randomized-controlled trial.

Pagnussat AS, Kleiner AFR, Rieder CRM, Frantz A, Ehlers J, Pinto C, Dorneles G, Netto CA, Peres A, Galli M.

Restor Neurol Neurosci. 2018;36(2):195-205. doi: 10.3233/RNN-170744.

PMID:
29526852
13.

Erratum: Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Chang-Castello J, Andreé-Munoz B, Waldherr S, Yearout D, Zabetian CP, Mata IF.

NPJ Parkinsons Dis. 2018 Jan 19;4:3. doi: 10.1038/s41531-017-0025-1. eCollection 2018.

14.

Automated Mechanical Peripheral Stimulation Improves Gait Parameters in Subjects With Parkinson Disease and Freezing of Gait: A Randomized Clinical Trial.

Pinto C, Pagnussat AS, Rozin Kleiner AF, Marchese RR, Salazar AP, Rieder CRM, Galli M.

Am J Phys Med Rehabil. 2018 Jun;97(6):383-389. doi: 10.1097/PHM.0000000000000890.

PMID:
29309313
15.

The future of pharmacogenetics in Parkinson's disease treatment.

Hutz MH, Rieder CR.

Pharmacogenomics. 2018 Feb;19(3):171-174. doi: 10.2217/pgs-2017-0180. Epub 2017 Dec 1. No abstract available.

PMID:
29191064
16.

Emergent lineages of mumps virus suggest the need for a polyvalent vaccine.

May M, Rieder CA, Rowe RJ.

Int J Infect Dis. 2018 Jan;66:1-4. doi: 10.1016/j.ijid.2017.09.024. Epub 2017 Oct 4.

17.

Brazilian Academy of Neurology (2006 - 2016).

Coelho FM, Castro LH, Fukujima MM, Adoni T, Rieder CRM, Bichuetti DB, Prado GFD, Gagliardi RJ.

Arq Neuropsiquiatr. 2017 Sep;75(9):635-638. doi: 10.1590/0004-282X20170095.

18.

Tumor necrosis factor alpha polymorphisms are associated with Parkinson's disease age at onset.

Lindenau JD, Altmann V, Schumacher-Schuh AF, Rieder CR, Hutz MH.

Neurosci Lett. 2017 Sep 29;658:133-136. doi: 10.1016/j.neulet.2017.08.049. Epub 2017 Aug 24.

PMID:
28844731
19.

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Chang-Castello J, Andreé-Munoz B, Waldherr S, Yearout D, Zabetian CP, Mata IF.

NPJ Parkinsons Dis. 2017 Jun 2;3:19. doi: 10.1038/s41531-017-0020-6. eCollection 2017. Erratum in: NPJ Parkinsons Dis. 2018 Jan 19;4:3.

20.

Different outcomes of phonemic verbal fluency in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.

Romann AJ, Beber BC, Olchik MR, Rieder CRM.

Arq Neuropsiquiatr. 2017 Apr;75(4):216-220. doi: 10.1590/0004-282X20170024.

21.

Instrument-mounted displays for reducing cognitive load during surgical navigation.

Herrlich M, Tavakol P, Black D, Wenig D, Rieder C, Malaka R, Kikinis R.

Int J Comput Assist Radiol Surg. 2017 Sep;12(9):1599-1605. doi: 10.1007/s11548-017-1540-6. Epub 2017 Feb 23.

22.

Benefit from the Chin-Down Maneuver in the Swallowing Performance and Self-Perception of Parkinson's Disease Patients.

Ayres A, Jotz GP, Rieder CR, Olchik MR.

Parkinsons Dis. 2017;2017:7460343. doi: 10.1155/2017/7460343. Epub 2017 Jan 19.

23.

Finding Optimal Ablation Parameters for Multipolar Radiofrequency Ablation.

Poch FGM, Rieder C, Ballhausen H, Knappe V, Ritz JP, Gemeinhardt O, Kreis ME, Lehmann KS.

Surg Innov. 2017 Jun;24(3):205-213. doi: 10.1177/1553350617692492. Epub 2017 Feb 13.

PMID:
28193132
24.

Deep Brain Stimulation Frequency of the Subthalamic Nucleus Affects Phonemic and Action Fluency in Parkinson's Disease.

Fagundes VC, Rieder CR, da Cruz AN, Beber BC, Portuguez MW.

Parkinsons Dis. 2016;2016:6760243. doi: 10.1155/2016/6760243. Epub 2016 Dec 5.

25.

Association between DNA methyltransferase gene polymorphism and Parkinson's disease.

Pezzi JC, de Bem CM, da Rocha TJ, Schumacher-Schuh AF, Chaves ML, Rieder CR, Hutz MH, Fiegenbaum M, Camozzato AL.

Neurosci Lett. 2017 Feb 3;639:146-150. doi: 10.1016/j.neulet.2016.12.058. Epub 2016 Dec 29.

PMID:
28041964
26.

Transarterial embolization (TAE) as add-on to percutaneous radiofrequency ablation (RFA) for the treatment of renal tumors: Review of the literature, overview of state-of-the-art embolization materials and further perspective of advanced image-guided tumor ablation.

Sommer CM, Pallwein-Prettner L, Vollherbst DF, Seidel R, Rieder C, Radeleff BA, Kauczor HU, Wacker F, Richter GM, Bücker A, Rodt T, Massmann A, Pereira PL.

Eur J Radiol. 2017 Jan;86:143-162. doi: 10.1016/j.ejrad.2016.10.024. Epub 2016 Nov 2. Review.

PMID:
28027741
27.

Association between DRD2 and DRD3 gene polymorphisms and gastrointestinal symptoms induced by levodopa therapy in Parkinson's disease.

Rieck M, Schumacher-Schuh AF, Altmann V, Callegari-Jacques SM, Rieder CRM, Hutz MH.

Pharmacogenomics J. 2018 Jan;18(1):196-200. doi: 10.1038/tpj.2016.79. Epub 2016 Oct 25.

PMID:
27779245
28.

The impact of cognitive performance on quality of life in individuals with Parkinson's disease.

Olchik MR, Ayres A, Ghisi M, Schuh AFS, Rieder CRM.

Dement Neuropsychol. 2016 Oct-Dec;10(4):303-309. doi: 10.1590/s1980-5764-2016dn1004008.

29.

Neuropsychological profile of Parkinson's disease patients selected for deep brain stimulation surgery.

Machado FA, Rieder CR, Hilbig A, Reppold CT.

Dement Neuropsychol. 2016 Oct-Dec;10(4):296-302. doi: 10.1590/s1980-5764-2016dn1004007.

30.

Evaluation of Knee Proprioception and Factors Related to Parkinson's Disease.

Ribeiro Artigas N, Eltz GD, do Pinho AS, Torman VB, Hilbig A, Rieder CR.

Neurosci J. 2016;2016:6746010. doi: 10.1155/2016/6746010. Epub 2016 Sep 8.

31.

Aspects of oral communication in patients with Parkinson's disease submitted to Deep Brain Stimulation.

Cruz AN, Beber BC, Olchik MR, Chaves ML, Rieder CR, Dornelles S.

Codas. 2016 Jul-Aug;28(4):480-5. doi: 10.1590/2317-1782/20162015169. Epub 2016 Aug 18. English, Portuguese.

32.

Postural instability and falls are more frequent in Parkinson's disease patients with worse trunk mobility.

Artigas NR, Franco C, Leão P, Rieder CR.

Arq Neuropsiquiatr. 2016 Jul;74(7):519-23. doi: 10.1590/0004-282X20160074.

33.

Brief considerations on the dispensation profile of the botulinum toxin type A by the Brazilian Unified Health System for treatment of dystonias: Datasus data.

Chien HF, Rosso ALZ, Santos ASD, Rieder CRM, Maia DP, Silva DJD, Andrade MDC, Coletta MVD, Costa MDDLD, Allam N, Prado RCPD, Borges V, Tumas V, Horta WG.

eNeurologicalSci. 2016 Jul 19;5:11-14. doi: 10.1016/j.ensci.2016.07.001. eCollection 2016 Dec.

34.

The Impact of Dysphagia Therapy on Quality of Life in Patients with Parkinson's Disease as Measured by the Swallowing Quality of Life Questionnaire (SWALQOL).

Ayres A, Jotz GP, Rieder CR, Schuh AF, Olchik MR.

Int Arch Otorhinolaryngol. 2016 Jul;20(3):202-6. doi: 10.1055/s-0036-1582450. Epub 2016 Apr 19.

35.

The vascular cooling effect in hepatic multipolar radiofrequency ablation leads to incomplete ablation ex vivo.

Poch FG, Rieder C, Ballhausen H, Knappe V, Ritz JP, Gemeinhardt O, Kreis ME, Lehmann KS.

Int J Hyperthermia. 2016 Nov;32(7):749-56. doi: 10.1080/02656736.2016.1196395. Epub 2016 Jul 11.

PMID:
27400818
36.

Minimal vascular flows cause strong heat sink effects in hepatic radiofrequency ablation ex vivo.

Lehmann KS, Poch FG, Rieder C, Schenk A, Stroux A, Frericks BB, Gemeinhardt O, Holmer C, Kreis ME, Ritz JP, Zurbuchen U.

J Hepatobiliary Pancreat Sci. 2016 Aug;23(8):508-16. doi: 10.1002/jhbp.370. Epub 2016 Jul 28.

PMID:
27338856
37.

Influence of genetic, biological and pharmacological factors on levodopa dose in Parkinson's disease.

Altmann V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, Rieder CR, Hutz MH.

Pharmacogenomics. 2016 Apr;17(5):481-8. doi: 10.2217/pgs.15.183. Epub 2016 Mar 29.

PMID:
27019953
38.

Effects of Nordic walking training on functional parameters in Parkinson's disease: a randomized controlled clinical trial.

Monteiro EP, Franzoni LT, Cubillos DM, de Oliveira Fagundes A, Carvalho AR, Oliveira HB, Pantoja PD, Schuch FB, Rieder CR, Martinez FG, Peyré-Tartaruga LA.

Scand J Med Sci Sports. 2017 Mar;27(3):351-358. doi: 10.1111/sms.12652. Epub 2016 Feb 2.

PMID:
26833853
39.

Clinical and Epidemiological Factors Associated with Mortality in Parkinson's Disease in a Brazilian Cohort.

Fernandes GC, Socal MP, Schuh AF, Rieder CR.

Parkinsons Dis. 2015;2015:959304. doi: 10.1155/2015/959304. Epub 2015 Dec 27.

40.

Val66Met BDNF polymorphism is associated with Parkinson's disease cognitive impairment.

Altmann V, Schumacher-Schuh AF, Rieck M, Callegari-Jacques SM, Rieder CR, Hutz MH.

Neurosci Lett. 2016 Feb 26;615:88-91. doi: 10.1016/j.neulet.2016.01.030. Epub 2016 Jan 21.

41.

Iron and Oxidative Stress in Parkinson's Disease: An Observational Study of Injury Biomarkers.

Medeiros MS, Schumacher-Schuh A, Cardoso AM, Bochi GV, Baldissarelli J, Kegler A, Santana D, Chaves CM, Schetinger MR, Moresco RN, Rieder CR, Fighera MR.

PLoS One. 2016 Jan 11;11(1):e0146129. doi: 10.1371/journal.pone.0146129. eCollection 2016.

42.

Assessment of Nonverbal and Verbal Apraxia in Patients with Parkinson's Disease.

Presotto M, Olchik MR, Shumacher Shuh AF, Rieder CR.

Parkinsons Dis. 2015;2015:840327. doi: 10.1155/2015/840327. Epub 2015 Oct 12.

43.

DNAJC6 Mutations Associated With Early-Onset Parkinson's Disease.

Olgiati S, Quadri M, Fang M, Rood JP, Saute JA, Chien HF, Bouwkamp CG, Graafland J, Minneboo M, Breedveld GJ, Zhang J; International Parkinsonism Genetics Network, Verheijen FW, Boon AJ, Kievit AJ, Jardim LB, Mandemakers W, Barbosa ER, Rieder CR, Leenders KL, Wang J, Bonifati V.

Ann Neurol. 2016 Feb;79(2):244-56. doi: 10.1002/ana.24553. Epub 2016 Jan 14.

PMID:
26528954
44.

Author Response.

Fernandes GC, Rieder CR, Vedolin L, Campos L, Koltermann T.

Neurology. 2015 Aug 18;85(7):655. No abstract available.

PMID:
26505051
45.

Overnight S100B in Parkinson's Disease: A glimpse into sleep-related neuroinflammation.

Carvalho DZ, Schönwald SV, Schumacher-Schuh AF, Braga CW, Souza DO, Oses JP, Donis KC, Rieder CR.

Neurosci Lett. 2015 Nov 3;608:57-63. doi: 10.1016/j.neulet.2015.10.010. Epub 2015 Oct 28.

PMID:
26453767
46.

Planning future clinical trials in Machado Joseph disease: Lessons from a phase 2 trial.

Saute JA, Rieder CR, Castilhos RM, Monte TL, Schumacher-Schuh AF, Donis KC, D'Ávila R, Souza GN, Russo AD, Furtado GV, Gheno TC, Souza DO, Saraiva-Pereira ML, Portela LV, Camey S, Torman VB, Jardim LB.

J Neurol Sci. 2015 Nov 15;358(1-2):72-6. doi: 10.1016/j.jns.2015.08.019. Epub 2015 Aug 14.

PMID:
26297649
47.

Experimental Evaluation of the Heat Sink Effect in Hepatic Microwave Ablation.

Ringe KI, Lutat C, Rieder C, Schenk A, Wacker F, Raatschen HJ.

PLoS One. 2015 Jul 29;10(7):e0134301. doi: 10.1371/journal.pone.0134301. eCollection 2015.

48.

Evaluation of quality of life and psychological aspects of Parkinson's disease patients who participate in a support group.

Artigas NR, Striebel VLW, Hilbig A, Rieder CRM.

Dement Neuropsychol. 2015 Jul-Sep;9(3):295-300. doi: 10.1590/1980-57642015DN93000013.

49.

Genetic of dystonias according the new classification.

Rieder CR.

Arq Neuropsiquiatr. 2015 Apr;73(4):281-2. doi: 10.1590/0004-282X20150058. Epub 2015 Apr 1. No abstract available.

50.

Interactive multi-criteria planning for radiofrequency ablation.

Schumann C, Rieder C, Haase S, Teichert K, Süss P, Isfort P, Bruners P, Preusser T.

Int J Comput Assist Radiol Surg. 2015 Jun;10(6):879-89. doi: 10.1007/s11548-015-1201-6. Epub 2015 Apr 23.

PMID:
25903775

Supplemental Content

Loading ...
Support Center